Intrexon | XON - Stock


Intrexon reported $287K in Stock for its fiscal quarter ending in December of 2022.





Stock Change Date
Amgen USD 6.19B 39M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.57B 13M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Incyte USD 115.62M 14.56M Mar/2026
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
MacroGenics USD 9.5M 1.59M Mar/2026
MannKind USD 49.17M 13.85M Mar/2026
Merck USD 6.48B 179M Mar/2026
Novartis USD 6.29B 17M Mar/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Thermo Fisher Scientific USD 5.5B 71M Mar/2026
Veracyte USD 21.42M 870K Mar/2026